Citation Impact
Citing Papers
Vertebral Fracture Assessment (VFA) With a Densitometer Predicts Future Fractures in Elderly Women Unselected for Osteoporosis
2008
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
2017 Standout
Bone regeneration: current concepts and future directions
2011 Standout
A new taxonomy for describing and defining adherence to medications
2012 Standout
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>
2003 Standout
Osteoporosis
2019 Standout
Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians
2017
Revisiting KDIGO clinical practice guideline on chronic kidney disease—mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference
2015
Prevalence of Vertebral Fractures in Men with Acromegaly
2008
The Waning of Teriparatide Effect on Bone Formation Markers in Postmenopausal Osteoporosis Is Associated with Increasing Serum Levels of DKK1
2011
The use of parathyroid hormone in the treatment of osteoporosis
2006
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
FRAX® with and without Bone Mineral Density
2011
Parathyroid Hormone as an Anabolic Skeletal Therapy
2005
Clinical Value of Prognostic Instruments to Identify Patients with an Increased Risk for Osteoporotic Fractures: Systematic Review
2011
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
2010
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Gout
2016 Standout
Osteoporosis, bone mineral density and CKD–MBD: treatment considerations
2017
Chronic arthritis leads to disturbances in the bone collagen network
2010 StandoutNobel
Epidemiology of Vertebral Fractures
2015
Interpretation and use of FRAX in clinical practice
2011
Management of severe osteoporosis
2015
Chronic Kidney Disease
2016 Standout
Incorporating adherence into health economic modelling of osteoporosis
2008
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: A multicenter longitudinal study
2011
Capturing Magnesium Ions via Microfluidic Hydrogel Microspheres for Promoting Cancellous Bone Regeneration
2021 Standout
Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism
2012
Vitamin D and Immune Function
2013 Standout
Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX
2012
The Molecular Physiology of Uric Acid Homeostasis
2014
Bone Mineral Density, Prevalence of Vertebral Fractures, and Bone Quality in Patients with Adrenal Incidentalomas with and without Subclinical Hypercortisolism: An Italian Multicenter Study
2009
β-Arrestin-biased ligands at seven-transmembrane receptors
2007 StandoutNobel
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
A β-Arrestin–Biased Agonist of the Parathyroid Hormone Receptor (PTH1R) Promotes Bone Formation Independent of G Protein Activation
2009 StandoutNobel
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
2016 Standout
Addressing unmeasured confounding in comparative observational research
2018 StandoutNobel
Effects of Previous Antiresorptive Therapy on the Bone Mineral Density Response to Two Years of Teriparatide Treatment in Postmenopausal Women with Osteoporosis
2007
Works of P. Chen being referenced
Enhanced prediction of fracture risk combining vertebral fracture status and BMD
2007
A simple method for determining the probability a new vertebral fracture is present in postmenopausal women with osteoporosis
2005
Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis
2008
Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover
2006
Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment
2006
Severity of vertebral fracture reflects deterioration of bone microarchitecture
2006